Viewing Study NCT00510250

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:05 PM
Ignite Modification Date: 2026-02-20 @ 3:32 PM
Study NCT ID: NCT00510250
Status: COMPLETED
Last Update Posted: 2015-07-27
First Post: 2007-07-31
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Phase I/II Study of Cisplatin and Radiation in Combination With Sorafenib in Cervical Cancer
Sponsor: University Health Network, Toronto
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cancer of the Cervix View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Cervix Cancer View
None Cervical Cancer View
None Sorafenib View
None Cisplatin View
None Radiation View
None Radiotherapy View
None Phase I View
None Phase II View
None Carcinoma View
None Cancer View
None Cervix View